Weekly ReportApr 28 – May 4, 2026
Anesthesiology, week 18 edition
We read 441 papers and selected 3.
Summary
This week highlights rapid progress in automation, perioperative pathways, and evidence synthesis in anesthesiology. A multicenter RCT validated a reinforcement learning–based automated anesthesia system showing non-inferior safety and faster induction for endoscopy. Large randomized and meta-analytic studies refined perioperative hemodynamic strategies and fast-track cardiac protocols, informing selection of individualized targets and extubation pathways. These findings push toward operational efficiency (automation, UFT) while emphasizing targeted, evidence-based personalization of perioperative care.
Selected Articles
1. Reinforcement learning based automated anesthesia system for gastrointestinal endoscopy with a multicenter randomized trial.
A multicenter randomized trial compared an RL-based automated anesthesia system (AAS-GE) for ciprofol delivery to clinician-managed anesthesia in GI endoscopy (n=418 validation cohort). Hypoxemia rates were non-inferior (≈14% both groups), induction time was shorter with automation, and total drug use and recovery time were similar. Increased intraoperative movement under automated control reflected a lighter anesthetic depth and indicates areas for optimization.
Impact: One of the first prospective multicenter RCTs validating RL-driven autonomous anesthesia, demonstrating safety parity with clinicians and operational efficiency gains—an important step toward scalable anesthesia automation.
Clinical Implications: Automated sedation systems may standardize care and alleviate staffing pressures for low-to-moderate risk procedures (e.g., endoscopy). Implementation should monitor anesthetic depth and movement, and test in higher-risk populations and with varied agents before broad adoption.
Key Findings
- Hypoxemia incidence similar between automated and clinician groups (~14%; OR 1.01; P=0.968).
- Induction time shorter with automation (median 1.55 vs 1.90 min; P<0.001).
- No increase in total drug dose or recovery time; intraoperative body movement was more frequent under automated control.
2. Evaluation of clinical impact of ultra fast-track versus conventional extubation in patients undergoing nonemergency cardiac surgery: 'CARDU-FAST': A randomised clinical trial.
In a single-center randomized trial of 612 nonemergency cardiac surgery patients, on-table (ultra fast-track, UFT) extubation did not significantly change a composite primary outcome (mortality/respiratory complications/AKI) but improved multiple secondary outcomes: reduced prolonged intubation, less need for noninvasive ventilation, fewer reoperations for bleeding, lower low cardiac output syndrome, and shorter ICU/hospital stays.
Impact: Largest randomized evaluation this week of immediate on-table extubation in cardiac anesthesia, offering actionable evidence that UFT can improve recovery metrics without increasing adverse signals in selected patients under standardized care.
Clinical Implications: Centers with standardized perioperative pathways may adopt UFT for selected cardiac surgery patients to shorten ventilation time and length of stay while maintaining safety monitoring; refine selection criteria and implement protocols for broader adoption.
Key Findings
- Primary composite outcome: 6.5% (UFT) vs 10.1% (FT), P=0.105 (no significant difference).
- UFT reduced prolonged intubation >24 h (2.0% vs 7.5%; P=0.001) and need for noninvasive ventilation (5.6% vs 11.1%; P=0.013).
- UFT lowered reoperations for bleeding and postoperative low cardiac output syndrome and shortened ICU/hospital length of stay.
3. Effect of individualised versus routine intraoperative blood pressure management on acute kidney injury in noncardiac surgery: a GRADE-assessed meta-analysis of randomised controlled trials.
A GRADE-assessed meta-analysis of 10 RCTs (n=5,842) found individualized intraoperative BP management reduced time spent below MAP 65 mmHg but did not significantly lower postoperative AKI, mortality, or myocardial injury; it was associated with a reduced incidence of postoperative delirium. Bayesian analysis suggested modest probability of AKI protection but low probability of clinically meaningful renal benefit.
Impact: High-quality synthesis that clarifies the limits of renal benefit from individualized BP targets while identifying a domain-specific neurocognitive benefit (reduced delirium), guiding prioritization of perioperative hemodynamic strategies.
Clinical Implications: Routine MAP targets (≥60–65 mmHg) remain reasonable for renal protection in many patients; individualized BP strategies may be considered when neurocognitive risk reduction (e.g., delirium) is a priority—implementation should balance complexity versus proven outcome gains.
Key Findings
- Individualized BP management reduced area under MAP <65 mmHg (mean difference −44.5 mmHg×min; P=0.0005).
- No significant reduction in postoperative AKI (RR 0.83; 95% CI 0.65–1.07).
- Postoperative delirium incidence significantly reduced (RR 0.46; 95% CI 0.25–0.83).